Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.09 | 18.53 |
| PEG Ratio (TTM) | -0.52 | 2.34 |
| P/S Ratio (TTM) | 1.60 | 7.52 |
| P/B Ratio (TTM) | 0.36 | 7.54 |
| P/FCF Ratio (TTM) | 10.11 | 37.78 |
| Price to 5YR AVG Earnings Ratio | N/A | -1.41 |
| Price to 5YR AVG FCF Ratio | N/A | -0.35 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.39% | 20.28% |
| ROE (TTM) | 7.30% | 29.42% |
| Net Profit Margin (TTM) | 13.33% | 1.53% |
| ROIC 5YR AVG | N/A | -35.35% |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 343.59% | 340.58% | N/A |
| Revenue | -0.64% | 5.10% | N/A |
| Net Income | 22.28% | 338.51% | N/A |
| Cash Flow | -11.04% | -0.59% | N/A |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.19 | 2.38 |
| Quick Ratio (TTM) | 2.19 | 2.38 |
| D/E Ratio (TTM) | 0.27 | 0.03 |
| Interest Coverage (TTM) | 7.65 | 286.87 |
| Piotroski F-Score | 9 | 7 |
| Altman Z-Score | 0.91 | 13.41 |
| LTL to 5YR AVG FCF | N/A | -0.94 |
| Shares Outstanding Growth 5YR AVG | N/A | 1,683.72% |